We are pleased to announce that Syvento will participate in the 10th Central European Congress of Life Sciences – EUROBIOTECH 2026, one of the leading biotechnology and life sciences events in Central Europe. Taking place on 2–3 July 2026 in Kraków, the anniversary edition of the congress will bring together scientists, biotechnology companies, industry leaders, investors, and innovation ecosystem stakeholders to discuss the future of life sciences and translational research.

As part of the Research in Biotech Industry track, Dominik Lipka, CTO & Board Member at Syvento, will join the panel discussion:

‘Development of Polish Biotechnology Companies – Research & Manufacturing Capacities’.

The discussion will focus on one of the most important challenges facing the Polish biotechnology sector: how to strengthen research excellence while expanding manufacturing capabilities and creating globally competitive biotech companies. The panel will explore the opportunities and barriers related to scaling innovation, technology transfer, industrial partnerships, and building a resilient biotech ecosystem.

Panel details

  • Date: 2 July 2026
  • Presentations: 9:50–11:05
  • Panel discussion: 11:35–12:50
  • Venue: EXPO Kraków, Poland

EUROBIOTECH has established itself as a key platform connecting academia with industry, fostering collaboration that accelerates the translation of scientific discoveries into real-world applications. The 10th edition is expected to be the largest yet, featuring more than 150 speakers across dozens of scientific and industry-focused sessions dedicated to biotechnology, AI, medical innovation, bioprocessing, sustainability, and commercialization.

For Syvento, participating in this discussion reflects our commitment to supporting the growth of the Polish biotechnology ecosystem through innovation, collaboration, and the development of technologies with global impact.

If you are attending EUROBIOTECH 2026, we invite you to join the session and connect with our team. We look forward to exchanging ideas, building new partnerships, and discussing how science and industry can work together to accelerate biotechnology innovation.